EU's ENVI committee unanimously supports tighter PMA-inclusive medtech regulatory regime
This article was originally published in Clinica
Executive Summary
The European Parliament's ENVI committee yesterday unanimously adopted its resolution intended to influence European Commission thinking on the proposed revision of the medical device directives, including a call for a shift to a premarket authorisation system for some high-risk devices.